ICD-10-CM Billable Code

M08.422

Pauciarticular juvenile rheumatoid arthritis, left elbow

Clinical Classification Guidelines

Medical Intelligence & Overview

Pauciarticular juvenile rheumatoid arthritis (JRA), also known as juvenile idiopathic arthritis, is a type of inflammatory joint disease that affects young children. When it involves four or fewer joints, it is classified as pauciarticular. This condition can impact various joints, with the left elbow being one of the common sites. It usually presents in children under the age of 16 and can cause pain, swelling, and stiffness, especially in the affected joint. Early diagnosis and management are essential to prevent joint damage and preserve mobility.

Causes & Symptoms

Clinical Causes: Genetic predisposition involving certain immune system genes Autoimmune response leading the body to attack its own joint tissues Environmental factors such as infections that may trigger immune responses Hormonal influences that affect immune regulation in children

Key Symptoms: Swelling around the affected elbow Pain or tenderness in the joint Stiffness, especially after periods of inactivity or in the morning Reduced range of motion in the elbow Limping or difficulty using the arm normally Occasional redness or warmth over the joint Possible systemic symptoms like low-grade fever or fatigue (less common)

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive clinical evaluation, including detailed medical history and physical examination focusing on joint swelling, tenderness, and mobility. Imaging tests like X-rays may be used to assess joint damage or inflammation, while blood tests can help identify inflammation markers and rule out other conditions. Because JRA is a diagnosis of exclusion, healthcare providers often perform tests to eliminate other causes of joint symptoms. In some cases, joint fluid analysis is also conducted to detect inflammation or infection.

Treatment Protocols: Management of pauciarticular juvenile rheumatoid arthritis typically involves a combination of therapies aimed at reducing inflammation, relieving pain, and maintaining joint function. Common treatment options include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to control pain and inflammation - Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, for more persistent cases - Corticosteroid injections directly into the affected joint for rapid relief - Physical therapy to improve joint flexibility, strength, and function - Regular monitoring by healthcare providers to assess disease activity and adjust treatment plans - Promoting gentle activities and exercises suitable for children to maintain mobility Ongoing care may involve a multidisciplinary team to address the physical and emotional needs of the child, ensuring optimal growth and development while managing the disease.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.422 a billable ICD-10 code?
Yes, M08.422 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.422?
Clinical documentation must specify the nature of Pauciarticular juvenile rheumatoid arthritis, left elbow and any associated comorbidities for accurate reporting.

Cite this Clinical Reference